Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

1.

Pharmacologic evidence to support clinical decision making for peripartum methadone treatment.

Bogen DL, Perel JM, Helsel JC, Hanusa BH, Romkes M, Nukui T, Friedman CR, Wisner KL.

Psychopharmacology (Berl). 2013 Jan;225(2):441-51. doi: 10.1007/s00213-012-2833-7. Epub 2012 Aug 25.

PMID:
22926004
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment.

Crettol S, Déglon JJ, Besson J, Croquette-Krokkar M, Gothuey I, Hämmig R, Monnat M, Hüttemann H, Baumann P, Eap CB.

Clin Pharmacol Ther. 2005 Dec;78(6):593-604.

PMID:
16338275
[PubMed - indexed for MEDLINE]
3.

CYP2B6 SNPs are associated with methadone dose required for effective treatment of opioid addiction.

Levran O, Peles E, Hamon S, Randesi M, Adelson M, Kreek MJ.

Addict Biol. 2013 Jul;18(4):709-16. doi: 10.1111/j.1369-1600.2011.00349.x. Epub 2011 Jul 25.

PMID:
21790905
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Estimated infant exposure to enantiomer-specific methadone levels in breastmilk.

Bogen DL, Perel JM, Helsel JC, Hanusa BH, Thompson M, Wisner KL.

Breastfeed Med. 2011 Dec;6(6):377-84. doi: 10.1089/bfm.2010.0060. Epub 2011 Feb 24.

PMID:
21348770
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Methadone dosing and prescribed medication use in a prospective cohort of opioid-dependent pregnant women.

Cleary BJ, Reynolds K, Eogan M, O'Connell MP, Fahey T, Gallagher PJ, Clarke T, White MJ, McDermott C, O'Sullivan A, Carmody D, Gleeson J, Murphy DJ.

Addiction. 2013 Apr;108(4):762-70. doi: 10.1111/add.12078. Epub 2013 Feb 11.

PMID:
23216809
[PubMed - indexed for MEDLINE]
6.

CYP2B6 polymorphisms influence the plasma concentration and clearance of the methadone S-enantiomer.

Wang SC, Ho IK, Tsou HH, Tian JN, Hsiao CF, Chen CH, Tan HK, Lin L, Wu CS, Su LW, Huang CL, Yang YH, Liu ML, Lin KM, Chen CY, Liu SC, Wu HY, Chan HW, Tsai MH, Lin PS, Liu YL.

J Clin Psychopharmacol. 2011 Aug;31(4):463-9. doi: 10.1097/JCP.0b013e318222b5dd.

PMID:
21694616
[PubMed - indexed for MEDLINE]
7.

Higher maternal doses of methadone does not increase neonatal abstinence syndrome.

Pizarro D, Habli M, Grier M, Bombrys A, Sibai B, Livingston J.

J Subst Abuse Treat. 2011 Apr;40(3):295-8. doi: 10.1016/j.jsat.2010.11.007. Epub 2011 Jan 20.

PMID:
21255960
[PubMed - indexed for MEDLINE]
8.

(R)- and (S)-methadone and buprenorphine concentration ratios in maternal and umbilical cord plasma following chronic maintenance dosing in pregnancy.

Gordon AL, Lopatko OV, Somogyi AA, Foster DJ, White JM.

Br J Clin Pharmacol. 2010 Dec;70(6):895-902. doi: 10.1111/j.1365-2125.2010.03759.x.

PMID:
21175445
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Alterations in methadone metabolism during late pregnancy.

Jarvis MA, Wu-Pong S, Kniseley JS, Schnoll SH.

J Addict Dis. 1999;18(4):51-61.

PMID:
10631963
[PubMed - indexed for MEDLINE]
10.

Changes in methadone maintenance therapy during and after pregnancy.

Albright B, de la Torre L, Skipper B, Price S, Abbott P, Rayburn W.

J Subst Abuse Treat. 2011 Dec;41(4):347-53. doi: 10.1016/j.jsat.2011.05.002. Epub 2011 Jul 7.

PMID:
21741197
[PubMed - indexed for MEDLINE]
11.

Impact of treatment approach on maternal and neonatal outcome in pregnant opioid-maintained women.

Metz V, Jagsch R, Ebner N, Würzl J, Pribasnig A, Aschauer C, Fischer G.

Hum Psychopharmacol. 2011 Aug;26(6):412-21. doi: 10.1002/hup.1224. Epub 2011 Aug 8.

PMID:
21823171
[PubMed - indexed for MEDLINE]
12.

Contribution of CYP2B6 alleles in explaining extreme (S)-methadone plasma levels: a CYP2B6 gene resequencing study.

Dobrinas M, Crettol S, Oneda B, Lahyani R, Rotger M, Choong E, Lubomirov R, Csajka C, Eap CB.

Pharmacogenet Genomics. 2013 Feb;23(2):84-93. doi: 10.1097/FPC.0b013e32835cb2e2.

PMID:
23249875
[PubMed - indexed for MEDLINE]
13.

Enantiomeric metabolic interactions and stereoselective human methadone metabolism.

Totah RA, Allen KE, Sheffels P, Whittington D, Kharasch ED.

J Pharmacol Exp Ther. 2007 Apr;321(1):389-99. Epub 2007 Jan 26.

PMID:
17259447
[PubMed - indexed for MEDLINE]
Free Article
14.

Quantitative prediction of CYP2B6 induction by estradiol during pregnancy: potential explanation for increased methadone clearance during pregnancy.

Dickmann LJ, Isoherranen N.

Drug Metab Dispos. 2013 Feb;41(2):270-4. doi: 10.1124/dmd.112.047118. Epub 2012 Jul 19.

PMID:
22815312
[PubMed - indexed for MEDLINE]
Free Article
15.

Prenatal methadone exposure, meconium biomarker concentrations and neonatal abstinence syndrome.

Gray TR, Choo RE, Concheiro M, Williams E, Elko A, Jansson LM, Jones HE, Huestis MA.

Addiction. 2010 Dec;105(12):2151-9. doi: 10.1111/j.1360-0443.2010.03097.x. Epub 2010 Sep 20.

PMID:
20854338
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Methadone trough levels in pregnancy.

Drozdick J 3rd, Berghella V, Hill M, Kaltenbach K.

Am J Obstet Gynecol. 2002 Nov;187(5):1184-8.

PMID:
12439500
[PubMed - indexed for MEDLINE]
17.

Opioid dependency in pregnancy and length of stay for neonatal abstinence syndrome.

Pritham UA, Paul JA, Hayes MJ.

J Obstet Gynecol Neonatal Nurs. 2012 Mar;41(2):180-90. doi: 10.1111/j.1552-6909.2011.01330.x. Epub 2012 Feb 29.

PMID:
22375882
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence.

Eap CB, Buclin T, Baumann P.

Clin Pharmacokinet. 2002;41(14):1153-93. Review.

PMID:
12405865
[PubMed - indexed for MEDLINE]
19.

Pharmacogenomics of CYP2A6, CYP2B6, CYP2C19, CYP2D6, CYP3A4, CYP3A5 and MDR1 in Vietnam.

Veiga MI, Asimus S, Ferreira PE, Martins JP, Cavaco I, Ribeiro V, Hai TN, Petzold MG, Björkman A, Ashton M, Gil JP.

Eur J Clin Pharmacol. 2009 Apr;65(4):355-63. doi: 10.1007/s00228-008-0573-8. Epub 2008 Nov 1.

PMID:
18979093
[PubMed - indexed for MEDLINE]
20.

Patterns of symptom reporting during pregnancy comparing opioid maintained and control women.

Gordon AL, Lopatko OV, Stacey H, Pearson V, Woods A, Fisk A, White JM.

J Addict Med. 2012 Dec;6(4):258-64. doi: 10.1097/ADM.0b013e31826b299d.

PMID:
23135165
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk